Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 4 2Phase 3 1

Status

Completed 5Withdrawn 1

Sponsor Class

OTHER 5

Study Type

Interventional 5

Sponsor

Cancer Type

Breast 5Genitourinary 1

Conditions

Breast Neoplasms 5

Interventions

Trastuzumab 379Paclitaxel 369Cyclophosphamide 338Docetaxel 314Capecitabine 198Doxorubicin 196Letrozole 183Tamoxifen 154Carboplatin 153Fulvestrant 136Bevacizumab 129Anastrozole 120exemestane 119Lapatinib 117Epirubicin 116Gemcitabine 112Radiotherapy 107palbociclib 93Exercise 87Fluorouracil 83Vinorelbine 82Surveys and Questionnaires 81pertuzumab 77Albumin-Bound Paclitaxel 76Filgrastim 71130-nm albumin-bound paclitaxel 64pembrolizumab 63Everolimus 59Cisplatin 59eribulin 58

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Completed × Alloderm × Breast × Clear all
NCT00956384 2024-12-05

AllodermRCT

University Health Network, Toronto

Phase NA Completed
198 enrolled 9 charts
Breast

Breast Neoplasms

NCT00639106 2018-10-03

Tissue Expander/Implant Reconstruction: A Single-Blinded, Randomized, Controlled Trial

Memorial Sloan Kettering Cancer Center

Phase 3 Completed
70 enrolled
Breast

Breast Neoplasms

NCT00872859 2017-05-18

The BREASTrial:Breast Reconstruction Evaluation Using Acellular Dermal Matrix as a Sling Trial

University of Utah

Phase 4 Completed
128 enrolled
Breast

Breast Neoplasms

NCT01561287 2016-05-11

A Comparison of Dermal Autograft to AlloDerm in Breast Reconstruction

University of Kentucky

Phase 4 Completed
48 enrolled
Breast

Breast Neoplasms

NCT01027637 2013-09-06

Regenerative Tissue Matrix for Breast Reconstruction

Henry Ford Health System

Phase NA Completed
33 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡